Eikon Therapeutics

Executive churn at pharma giant Merck & Co., Inc. (NYSE: MRK) has increased in recent times, so much so that it has caused stakeholders to sit up and take notice. What Happened: As recently as Wednesday, New Jersey-based Merck said Roy Baynes, who is serving as head of Global Clinical...